HAPV3 Stock Overview
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the health sector in Brazil.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HAPV3 from our risk checks.
Hapvida Participações e Investimentos S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$3.60 |
| 52 Week High | R$5.42 |
| 52 Week Low | R$2.44 |
| Beta | 0.55 |
| 1 Month Change | -6.49% |
| 3 Month Change | -10.22% |
| 1 Year Change | 44.58% |
| 3 Year Change | -75.51% |
| 5 Year Change | -40.52% |
| Change since IPO | -37.61% |
Recent News & Updates
Is Hapvida Participações e Investimentos (BVMF:HAPV3) A Risky Investment?
Mar 28
Investors Still Waiting For A Pull Back In Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)
Jan 07Recent updates
Is Hapvida Participações e Investimentos (BVMF:HAPV3) A Risky Investment?
Mar 28Investors Still Waiting For A Pull Back In Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)
Jan 07Hapvida Participações e Investimentos (BVMF:HAPV3) Is Making Moderate Use Of Debt
Dec 11Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Sep 11Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Jun 08Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Can Afford Some Debt
Feb 27Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Somewhat Strained Balance Sheet
Nov 11At R$8.13, Is It Time To Put Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) On Your Watch List?
Sep 11Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Meaningful Debt Burden
Jul 08Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?
Mar 27We Think Hapvida Participações e Investimentos (BVMF:HAPV3) Is Taking Some Risk With Its Debt
Dec 28Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?
Nov 23Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Sep 10Should You Think About Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Now?
Aug 06Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
May 12The Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Annual Results Are Out And Analysts Have Published New Forecasts
Mar 20Introducing Hapvida Participações e Investimentos (BVMF:HAPV3), A Stock That Climbed 55% In The Last Year
Mar 10Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet
Feb 11
Is Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Jan 07Investors Who Bought Hapvida Participações e Investimentos (BVMF:HAPV3) Shares A Year Ago Are Now Up 34%
Dec 10Shareholder Returns
| HAPV3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 1.7% | 4.0% | 0.7% |
| 1Y | 44.6% | 5.2% | 14.9% |
Price Volatility
| HAPV3 volatility | |
|---|---|
| HAPV3 Average Weekly Movement | 5.3% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 8.7% |
| 10% least volatile stocks in BR Market | 2.3% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | n/a | Jorge Fontoura Pinheiro de Lima | ri.hapvida.com.br |
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the health sector in Brazil. The company offers medical and dental insurance plans. It also provides medical and paramedical, laboratory, diagnostic, imaging, and ultrasound services, as well as organizes courses, lectures, seminars, and other events.
Hapvida Participações e Investimentos S.A. Fundamentals Summary
| HAPV3 fundamental statistics | |
|---|---|
| Market cap | R$27.06b |
| Earnings (TTM) | -R$739.89m |
| Revenue (TTM) | R$27.38b |
1.0x
P/S Ratio-36.5x
P/E RatioIs HAPV3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HAPV3 income statement (TTM) | |
|---|---|
| Revenue | R$27.38b |
| Cost of Revenue | R$20.31b |
| Gross Profit | R$7.07b |
| Other Expenses | R$7.81b |
| Earnings | -R$739.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | -0.099 |
| Gross Margin | 25.81% |
| Net Profit Margin | -2.70% |
| Debt/Equity Ratio | 23.6% |
How did HAPV3 perform over the long term?
See historical performance and comparison